Tuesday, November 1, 2011
(HealthDay News) — Multiple sclerosis patients may eventually benefit from a novel treatment that takes aim at the abnormal behavior of a specific type of immune cell, preliminary research suggests. The errant behavior of the cells in question — known as "B cells" — is viewed as key to the development of this chronic and [...]
(HealthDay News) — Pregnancy is generally safe for women with multiple sclerosis, a new study says. Canadian researchers analyzed 432 births to women with MS and almost 3,000 births to women without MS in the province of British Columbia between 1998 and 2009. They found no significant differences in either timing of delivery or birth [...]
(HealthDay News) — Black people with multiple sclerosis are more likely to have vitamin D deficiencies than blacks who don’t have the disease, a new study shows. The study, published in the May 24 issue of the journal Neurology, also said the deficiency is due primarily to differences in climate and geography. "MS is not [...]
HealthDay News — A new oral medication for the treatment of multiple sclerosis MS shows promise in slowing disease progression, limiting brain atrophy and reducing MS relapses, a recently completed two-year clinical trial demonstrates.The findings concern the experimental drug laquinimod, and stem from work with over 1,100 MS patients at 139 medical facilities in 24 [...]
I apologize in advance for posting this, as it can’t possibly be news to anyone with half a brain. (HealthDay News) — As the debate over medical marijuana use continues, a new study among multiple sclerosis patients — who often use the drug to relieve pain and muscle spasticity — adds to the argument that [...]
(AFP) – German pharmaceutical group Merck KgaA said Wednesday that the US Food and Drug Administration (FDA) has refused to approve use of its multiple sclerosis treatment Cladribine. The FDA declined to approve the drug "in its present form" and asked Merck to "provide an improved understanding of the safety risks and the overall benefit-risk [...]
(HealthDay News) — U.S. scientists say they’ve coaxed human embryonic stem cells into generating cells that might someday be used to repair nerves damaged by multiple sclerosis. The researchers pushed the stem cells to grow into critical nervous system support cells called oligodendrocytes, according to a report released Thursday. Read on
(HealthDay News) — People with multiple sclerosis may have a lower overall risk of developing cancer, Swedish researchers report. The study, which tracked the medical records of more than 20,000 MS patients for 35 years, “found that they had some 10 percent decreased overall cancer risk compared with those without the disease,” said lead researcher [...]
Thursday, October 26, 2006
You may remember my rant after I was ticketed by the City of El Cerrito because they apparently didn’t realize they had to honor my disabled parking placard from Connecticut. For anyone who runs into the same situation, here is the relevant state code that allows you to use your out-of-state placard: California Vehicle Code [...]
Also filed in
|
|
Thursday, October 19, 2006
Generally I try not to piss and moan too much about having MS. It doesn’t really do much good, does it? Doesn’t change anything. But I was just reminded about how much having MS can really suck. Yesterday I was having a somewhat tough day with my MS. I was sick on Monday with something [...]
Also filed in
|
|